ACS Clinical Research Program rss

ACS CRP

Early-stage prostate cancer decision aids for diverse patient populations(0)

April 1, 2020

The aim of the Alliance A191402CD trial is to evaluate the use of decision aids for men choosing treatment for located prostate cancer, particularly in minority populations.

ACS Clinical Research Program

What is the National Clinical Trials Network, and how do I join?

A summary of the structure and function of the National Cancer Institute’s National Clinical Trial Network is provided.

ACS CRP

ACS Clinical Research Program sessions at Clinical Congress 2019: A recap

A summary of the ACS Clinical Research Program sessions at Clinical Congress 2019 is provided.

ACS CRP

Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial

The study design and findings of the PRODIGE 24/CCTG PA6 Trial are outlined, which showed improved survival with modified FOLFIRINOX for resected pancreatic cancer patients.

Figure 1. Schema: ALCHEMIST CHEMO-IO

ALCHEMIST trial has potential to improve outcomes after lung cancer resection

The ALCHEMIST CHEMO-IO is a trial for patients with early-stage non-small cell lung cancer (NSCLC) with the potential to change the way patients with resected NSCLC are treated.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611

Archives

Download the Bulletin App

Apple Store
Get it on Google Play
Amazon store